NutraIngredients has announced the inaugural two-day Nutra Healthspan Summit in London, convening leading scientists, industry stakeholders, and investors to examine market dynamics, hallmarks of aging, and next-generation bioactives like NR, NMN, and spermidine through panels, roundtables, and startup pitches.

Key points

• Summit agendas encompass hallmarks of aging, exploring pathways such as mitochondrial function and cellular senescence to guide translational healthspan strategies.
• Next-gen bioactives sessions highlight compounds like nicotinamide riboside, NMN, urolithin A, and spermidine, emphasizing mechanisms of action and clinical potential.
• Investor-focused startup competition and curated 1-on-1 meetings foster commercialization of early-stage longevity ventures and facilitate industry-academia partnerships.

Why it matters: Bridging nutritional science and investment catalyzes development of validated healthspan interventions, accelerating translation of aging research into market-ready therapies.